Belay Diagnostics
Honey Reddi, PhD, FACMG has a vast experience in the field of genetics and genomics. They have worked in various prestigious institutions and companies, specializing in clinical laboratory operations, research, and business development. Honey has also been involved in teaching and course direction in the area of precision medicine. With a strong educational background in biotechnology and genetics, they have made significant contributions in translational research, biomarker discovery, and viro-therapeutics, particularly focused on thyroid cancer. Honey's expertise and leadership have been instrumental in the development and implementation of clinical diagnostic programs, collaborations, and growth initiatives in the healthcare industry.
This person is not in any teams
Belay Diagnostics
1 followers
Belay Diagnostics provides next-gen sequencing to detect aneuploidy and mutations with our cerebrospinal fluid testing platform. Improving diagnosis for brain and spinal cord cancers can give people the best chance for a cure without the need for invasive biopsies. We see our technological advances in cerebrospinal fluid assays as offering clinicians alternative diagnostic tools for use in treatment decisions.